AI Article Synopsis
- Immunohistochemistry (IHC) is a crucial technique used in breast cancer diagnosis and treatment, allowing for the identification of specific proteins in tissue samples.
- Despite its significance, there are still many challenges in standardizing IHC results across different laboratories, impacting its reliability and consistency.
- The review discusses the evolution of IHC, highlights existing problems, and suggests potential solutions and future approaches to improve its clinical use.
Article Abstract
Immunohistochemistry (IHC) has become an indispensable tool in the clinical practices for breast cancer; however, to achieve its standardization, numerous issues need to be overcome. In this review, we describe the development of IHC as an important clinical tool, and the challenges in standardizing IHC results for patients. We also present ideas for resolving the remaining issues and unmet needs, along with future directions.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986307 | PMC |
| http://dx.doi.org/10.1267/ahc.22-00050 | DOI Listing |
Publication Analysis
Top Keywords
clinical practices
8
breast cancer
8
application immunohistochemistry
4
immunohistochemistry clinical
4
practices standardized
4
standardized assay
4
assay breast
4
cancer immunohistochemistry
4
immunohistochemistry ihc
4
ihc indispensable
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!